Impact of Cytomegalovirus Disease in D+/R- Kidney Transplant Patients Receiving 6 Months Low-Dose Valganciclovir Prophylaxis

American Journal of Transplantation - United Kingdom
doi 10.1111/j.1600-6143.2011.03611.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley


Related search